Tower Research Capital LLC (Trc) Biocept Inc Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.24 - $0.62 $4 - $10	-17 Reduced 0.2%	8,369 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.47 - $0.89 $250 - $473	-532 Reduced 5.97%	8,386 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.75 - $1.2 $1,131 - $1,809	-1,508 Reduced 14.46%	8,918 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $2.27 $7,780 - $20,071	8,842 Added 558.21%	10,426 $10,000
Q1 2022 May 12, 2022	SELL	$1.83 - $3.97 $768 - $1,667	-420 Reduced 20.96%	1,584 $4,000
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.22 $6,873 - $8,456	2,004 New	2,004 $7,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.